-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E0FEb+0682b8cbUUHL8Cwk4MI/zcYdRcSACTZzvLq0k7IiGqEn0ibmWXUPjEy31f 31InYy6g+FC8Y4urV0vpHQ== 0000910680-07-000392.txt : 20070510 0000910680-07-000392.hdr.sgml : 20070510 20070510183100 ACCESSION NUMBER: 0000910680-07-000392 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070510 FILED AS OF DATE: 20070510 DATE AS OF CHANGE: 20070510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biodel Inc CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 6 CHRISTOPHER COLUMBUS AVE CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 203-798-3603 MAIL ADDRESS: STREET 1: 6 CHRISTOPHER COLUMBUS AVE CITY: DANBURY STATE: CT ZIP: 06810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KROIN DAVID CENTRAL INDEX KEY: 0001397513 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 07839483 BUSINESS ADDRESS: BUSINESS PHONE: 203-798-3603 MAIL ADDRESS: STREET 1: C/O BIODEL INC STREET 2: 6 CHRISTOPHER COLUMBUS AVENUE CITY: DANBURY STATE: CT ZIP: 06810 3 1 f3kroin_ex.xml FORM 3 - DAVID KROIN X0202 3 2007-05-10 0 0001322505 Biodel Inc BIOD 0001397513 KROIN DAVID C/O BIODEL INC 6 CHRISTOPHER COLUMBUS AVENUE DANBURY CT 06810 1 0 0 0 Common Stock 318 D Common Stock 707818 I See footnote Director Stock Option (right to buy) 5.65 2014-07-10 Common Stock 17713 D Director Stock Option (right to buy) 12.63 2014-11-30 Common Stock 2601 D Director Stock Option (right to buy) 15.00 2007-05-10 2017-05-09 Common Stock 25000 D Series B Convertible Preferred Stock Common Stock 1258756 I See footnote The amount shown represents the beneficial ownership of the Issuer's securities by affiliates of Great Point Partners I, L.P., which may be deemed attributable to the Reporting Person because the Reporting Person is a co-founder and managing director of Great Point Partners I, L.P. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. This option is exercisable in two equal installments on July 11, 2007 and July 11, 2008. This option is exercisable in two equal installments on December 1, 2007 and December 1, 2008. The Series B Convertible Preferred Stock has no expiration date. It is immediately convertible and will automatically convert into Common Stock of the Issuer upon the close of the Issuer's initial public offering on a one for one basis. /s/ David Kroin 2007-05-10 -----END PRIVACY-ENHANCED MESSAGE-----